U.S. Markets closed
  • S&P Futures

    3,682.25
    -26.75 (-0.72%)
     
  • Dow Futures

    29,481.00
    -188.00 (-0.63%)
     
  • Nasdaq Futures

    11,300.75
    -76.00 (-0.67%)
     
  • Russell 2000 Futures

    1,672.30
    -13.80 (-0.82%)
     
  • Crude Oil

    78.72
    -0.02 (-0.03%)
     
  • Gold

    1,647.80
    -7.80 (-0.47%)
     
  • Silver

    18.63
    -0.28 (-1.48%)
     
  • EUR/USD

    0.9653
    -0.0036 (-0.3668%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0574
    -0.0283 (-2.6054%)
     
  • USD/JPY

    143.8000
    +0.4800 (+0.3349%)
     
  • BTC-USD

    18,831.21
    -144.17 (-0.76%)
     
  • CMC Crypto 200

    432.09
    -12.45 (-2.80%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    26,531.54
    -622.29 (-2.29%)
     

Insiders Roundup: Mastercard, Eli Lilly

·4 min read

The GuruFocus All-in-One Screener can be used to find insider trades from a specific period of time or for a certain range of values. For these stock picks, I went under the Insiders tab and changed the settings for All Insider Buying to "$2,000,000+," the duration to "July 2020" and All Insider Sales to "$2,000,000+."


According to these filters, the following are this past week's most significant trades from company insiders.

Texas Pacific Land Trust

Horizon Kinetics Asset Management, 10% owner of Texas Pacific Land Trust (TPL), bought a combined 580 shares for an average price of $107 per share on July 6, 7 and 8.

e0d1f8cc7ba3ea5b4cb4f94820d0d330.png
e0d1f8cc7ba3ea5b4cb4f94820d0d330.png

The oil and gas company has a market cap of $4.21 billion and an enterprise value of $3.99 billion. It has insider ownership of 0.82% and institutional ownership of 17.37%.

Over the past 12 months, the stock has lost 31%. As of Friday, it was trading 35.29% below its 52-week high and 83.9% above its 52-week low.

Continental Resources

Harold Hamm, Executive Chairman and 10% owner of Continental Resources Inc. (CLR), bought 2.6 million shares for an average price of $17.77 per share on July 7.

4bd061b63b7fd89d65b0b7314107f789.png
4bd061b63b7fd89d65b0b7314107f789.png

The oil and gas producer has a market cap of $5.51 billion and an enterprise value of $11.35 billion. It has insider ownership of 3.59% and institutional ownership of 13.99%.

Over the past 12 months, the stock has lost 63%. As of Friday, it was trading 64.58% below its 52-week high and 118.55% above its 52-week low.

Mastercard

10% owner Mastercard Foundation sold 206,010 shares of Mastercard Inc. (NYSE:MA) for an average price of $303.73 per share on July 8.

5894945fb007079f1ebb25e8c559bae9.png
5894945fb007079f1ebb25e8c559bae9.png

The credit card manager has a market cap of $299 billion and an enterprise value of $300 billion. It has insider ownership of 0.15% and institutional ownership of 53.76%.

Over the past 12 months, the stock has increased 7%. As of Friday, shares were trading 15.16% below the 52-week high and 47.30% above the 52-week low.

BeiGene

CEO John Oyler, Chair of Scientific Advisory Board Xiadong Wang and Chief Medical Officer of Hermatology Jane Huang sold a combined 63,835 shares of BeiGene Ltd. (BGNE) on July 7 and 8 for an average price of $200 per share.

fe166eacf2ae05980a4991067d8ed07a.png
fe166eacf2ae05980a4991067d8ed07a.png

The biopharmaceutical company has a market cap of $15.57 billion and an enterprise value of $12.50 billion. It has insider ownership of 0.43% and institutional ownership of 43.12%.

Over the past 12 months, the stock has increased 55.31%. As of Friday, shares were trading 5.01% below the 52-week high and 74.64% above the 52-week low.

ChemoCentryx

Vifor International Ltd. sold 266,077 shares of ChemoCentryx Inc. (CCXI) for an average price of $59.24 per share on July 8.

91afe75119b77edf80888a282b104f04.png
91afe75119b77edf80888a282b104f04.png

The biopharmaceutical company has a market cap of $4 billion. It has insider ownership of 4.61% and institutional ownership of 49.26%.

Over the past 12 months, the stock has gained 569%. As of Friday, shares were trading 9.71% below the 52-week high and 859% above the 52-week low.

Eli Lilly

Lilly Endowment Inc., 10% owner of Eli Lilly and Co. (LLY), sold a combined 415,000 shares for an average price of $167 per share on July 6 and 7.

6c54b1136a2419b6883aaab9025a0df5.png
6c54b1136a2419b6883aaab9025a0df5.png

The pharmaceutical company has a market cap of $159 billion and an enterprise value of $174 billion. It has insider ownership of 0.45% and institutional ownership of 52.89%.

Over the past 12 months, the stock has climbed 47.20%. As of Friday, shares were trading 2.52% below the 52-week high and 64.22% above the 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.